Allena stock: buy or sell?
February 27th, 2020
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.
Should I buy Allena stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Allena Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Allena Pharmaceuticals stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for ALNA stock for the last 30 days.
Allena stock analysis
Shares of Allena Pharmaceuticals plummed a dreadful -7.01% and closed at $1.99.
Allena Pharmaceuticals plummed a dreadful -7.01% and closed at $1.99. Since November when ALNA stock price broke down the SMA200d line, it slid $-3.86 per share (-65.98%). ALNA marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $2.38 would break this short term down trend and open possibilities for reversing this situation.
Shares of Allena Pharmaceuticals plummed a bloodcurdling -7.87% this week. Late January ALNA boosted an exceptional 8.24% in just one week.
Allena finally dropped through the support and now is sliding further into lower prices looking for new supports.
Allena stock price history
Allena IPO was on November 2nd, 2017 at $12.40 per share1. Since then, ALNA stock sliced a -84.00%, with a yearly average of -42.00%.
1: Adjusted price after possible price splits or reverse-splits.
Allena stock historical price chart
ALNA stock reached 52-week highs on March at $7.95, and all-time highs 2018-04-03 with a price of 17.56.
Allena stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ALNA stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price forecast for Allena stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareOn March, Allena failed to meet the forecasts of the analysts and posted a tragic EPS of $-0.46 per share when experts were expecting $-0.51.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn , Allena annual revenues to M USD from marked in . , its earnings margin (compared to revenues) to , that is million.
Quarterly financial resultsReported quarter income marked $-9.61 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Allena sales marked a neutral movement and remained steady a nan%. Looking back to recent quarterly results, Allena Pharmaceuticals posted 5 positive quarters in a row.
Allena ownershipWhen you are planning to buy shares of a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Allena Pharmaceuticals, 12.46% of all outstanding shares are owned by its staff.
In case of Allena stock, 74.99% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ALNA stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Allena Pharmaceuticals:
|Market cap||$46.7 M|
|Total shares||23.5 M|
|Float shares||13.4 M|
|- Institutional holdings (%)||75.0%|
|- Insider holdings (%)||12.5%|
|Shares in short selling||0.0%|
|Thursday, February 27th, 2020|
|Day range||$1.93 - $2.08|
|Average true range||$0.25|
|50d mov avg||$2.43|
|100d mov avg||$2.95|
|200d mov avg||$3.67|
Allena performanceTo better understand Allena performance you must compare its gains with other related stocks in same sector or industry. For Allena Pharmaceuticals, the benchmark is made against .